Fuan Pharmaceutical (300194.SZ) announced first-half results, with net profit of 957.748 million yuan to mother, a year-on-year decrease of 15.33%

According to the Zhitong Finance App, Fuan Pharmaceutical (300194.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved revenue of 839 million yuan, a year-on-year decrease of 8.82%. Net profit attributable to shareholders of listed companies was 95.7748 million yuan, a year-on-year decrease of 15.33%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 86.4366 million yuan, a year-on-year decrease of 16.93%.